CUAMC
China Universal Asset Management Company’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.9K | Buy |
11,837
+140
| +1% | +$661 | 0.01% | 411 |
|
|
2025
Q1 | $53.7K | Sell |
11,697
-666
| -5% | -$3.06K | 0.01% | 415 |
|
|
2024
Q4 | $59.2K | Buy |
12,363
+1,152
| +10% | +$5.52K | 0.01% | 442 |
|
|
2024
Q3 | $52.6K | Buy |
11,211
+4,374
| +64% | +$20.5K | 0.01% | 384 |
|
|
2024
Q2 | $38.6K | Sell |
6,837
-4,208
| -38% | -$23.8K | 0.01% | 373 |
|
|
2024
Q1 | $45.4K | Buy |
11,045
+4,387
| +66% | +$18K | 0.01% | 416 |
|
|
2023
Q4 | $28.1K | Buy |
6,658
+5,186
| +352% | +$21.9K | 0.01% | 403 |
|
|
2023
Q3 | $6.36K | Buy |
1,472
+719
| +95% | +$3.11K | ﹤0.01% | 376 |
|
|
2023
Q2 | $4.96K | Sell |
753
-16
| -2% | -$105 | ﹤0.01% | 368 |
|
|
2023
Q1 | $5.22K | Buy |
769
+194
| +34% | +$1.32K | ﹤0.01% | 361 |
|
|
2022
Q4 | $4.25K | Buy |
575
+45
| +8% | +$333 | ﹤0.01% | 314 |
|
|
2022
Q3 | $5K | Buy |
+530
| New | +$5K | ﹤0.01% | 278 |
|